Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor

This publication has 28 references indexed in Scilit:

• The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling
  Journal of Biological Chemistry, 1997
• Enhanced Tumorigenic Behavior of Glioblastoma Cells Expressing a Truncated Epidermal Growth Factor Receptor Is Mediated through the Ras-Shc-Grb2 Pathway
  Journal of Biological Chemistry, 1996
• EGFR gene amplification ‐ rearrangement in human glioblastomas
  International Journal of Cancer, 1995
• A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
  Proceedings of the National Academy of Sciences, 1994
• Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastoma
  International Journal of Cancer, 1994
• Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor
  Cell, 1993
• Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases
  Nature, 1992
• Structural alterations of the epidermal growth factor receptor gene in human gliomas.
  Proceedings of the National Academy of Sciences, 1992
• Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.
  Proceedings of the National Academy of Sciences, 1990
• Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors.
  Molecular and Cellular Biology, 1988